Welcome to LookChem.com Sign In|Join Free

CAS

  • or

675112-70-6

Post Buying Request

675112-70-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

675112-70-6 Usage

Uses

Different sources of media describe the Uses of 675112-70-6 differently. You can refer to the following data:
1. Cyclohexyl-substituted pyrrolidinones
2. Cyclohexyl-substituted pyrrolidinones and their use as inhibitors of 11-β-hydroxysteroid dehydrogenase 1.

Check Digit Verification of cas no

The CAS Registry Mumber 675112-70-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,5,1,1 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 675112-70:
(8*6)+(7*7)+(6*5)+(5*1)+(4*1)+(3*2)+(2*7)+(1*0)=156
156 % 10 = 6
So 675112-70-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H11F2N.ClH/c7-6(8)3-1-5(9)2-4-6;/h5H,1-4,9H2;1H

675112-70-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,4-Difluorocyclohexylamine hydrochloride

1.2 Other means of identification

Product number -
Other names 4,4-difluorocyclohexan-1-amine,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:675112-70-6 SDS

675112-70-6Relevant articles and documents

Iridinesulfonamide compound and use method thereof

-

, (2018/03/29)

An iridinesulfonamide compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity, pharmaceutically-acceptable salts, solvates or hydrates thereof, a pharmaceutical composition, as well as use of the compound or the pharmaceutically-acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition thereof in treating IDH1 mutation-induced cancers.

THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF

-

Page/Page column 64; 66, (2015/02/19)

Provided are therapeutically active compounds and the use in manufacture of medicaments for treating a cancer characterized by the presence of a mutant allele of IDH1.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

Page/Page column, (2015/03/31)

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 675112-70-6